Request for Covid-19 Impact Assessment of this Report

Take Action
Diagnostic and Biotech

Europe Prostate Specific Antigen PSA Testing Market Report 2021

  • QYR649182
  • 106 Pages
  • August 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Prostate Specific Antigen (PSA) Testing

Revenue, means the sales value of Prostate Specific Antigen (PSA) Testing

This report studies sales (consumption) of Prostate Specific Antigen (PSA) Testing in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Abbott Laboratories, Inc

Bayer AG

Beckman Coulter, Inc

GE Helathcare

GlaxoSmithKline, plc

Novartis Pharma AG

UroLogix, Inc

Bristol - Myers Squibb Company

AstraZeneca plc

Johnson & Johnson Diagnostics

BioChem Pharma

Pharmacia Delfia

Roche Diagnostics

Olympus

Tosho

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Prostate Specific Antigen (PSA) Testing in these regions, from 2011 to 2021 (forecast), like

Germany

France

UK

Italy

Spain

Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Free Prostate Specific Antigen Test

Complex Prostate Specific Antigen Test

Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test

Split by applications, this report focuses on sales, market share and growth rate of Prostate Specific Antigen (PSA) Testing in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

1 Prostate Specific Antigen (PSA) Testing Overview

1.1 Product Overview and Scope of Prostate Specific Antigen (PSA) Testing

1.2 Classification of Prostate Specific Antigen (PSA) Testing

1.2.1 Free Prostate Specific Antigen Test

1.2.2 Complex Prostate Specific Antigen Test

1.2.3 Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test

1.3 Applications of Prostate Specific Antigen (PSA) Testing

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Prostate Specific Antigen (PSA) Testing Market by Regions

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Italy Status and Prospect (2011-2021)

1.4.5 Spain Status and Prospect (2011-2021)

1.4.6 Russia Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Prostate Specific Antigen (PSA) Testing (2011-2021)

1.5.1 Europe Prostate Specific Antigen (PSA) Testing Sales, Revenue and Price (2011-2021)

1.5.2 Europe Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

1.5.3 Europe Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

2 Europe Prostate Specific Antigen (PSA) Testing by Manufacturers, Type and Application

2.1 Europe Prostate Specific Antigen (PSA) Testing Market Competition by Manufacturers

2.1.1 Europe Prostate Specific Antigen (PSA) Testing Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Prostate Specific Antigen (PSA) Testing Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Prostate Specific Antigen (PSA) Testing (Volume and Value) by Type

2.2.1 Europe Prostate Specific Antigen (PSA) Testing Sales and Market Share by Type (2011-2021)

2.2.2 Europe Prostate Specific Antigen (PSA) Testing Revenue and Market Share by Type (2011-2021)

2.3 Europe Prostate Specific Antigen (PSA) Testing (Volume and Value) by Regions

2.3.1 Europe Prostate Specific Antigen (PSA) Testing Sales and Market Share by Regions (2011-2021)

2.3.2 Europe Prostate Specific Antigen (PSA) Testing Revenue and Market Share by Regions (2011-2021)

2.4 Europe Prostate Specific Antigen (PSA) Testing (Volume) by Application

3 Germany Prostate Specific Antigen (PSA) Testing (Volume, Value and Sales Price)

3.1 Germany Prostate Specific Antigen (PSA) Testing Sales and Value (2011-2021)

3.1.1 Germany Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

3.1.2 Germany Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

3.1.3 Germany Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

3.2 Germany Prostate Specific Antigen (PSA) Testing Sales and Market Share by Manufacturers

3.3 Germany Prostate Specific Antigen (PSA) Testing Sales and Market Share by Type

3.4 Germany Prostate Specific Antigen (PSA) Testing Sales and Market Share by Applications

4 UK Prostate Specific Antigen (PSA) Testing (Volume, Value and Sales Price)

4.1 UK Prostate Specific Antigen (PSA) Testing Sales and Value (2011-2021)

4.1.1 UK Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

4.1.2 UK Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

4.1.3 UK Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

4.2 UK Prostate Specific Antigen (PSA) Testing Sales and Market Share by Manufacturers

4.3 UK Prostate Specific Antigen (PSA) Testing Sales and Market Share by Type

4.4 UK Prostate Specific Antigen (PSA) Testing Sales and Market Share by Applications

5 France Prostate Specific Antigen (PSA) Testing (Volume, Value and Sales Price)

5.1 France Prostate Specific Antigen (PSA) Testing Sales and Value (2011-2021)

5.1.1 France Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

5.1.2 France Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

5.1.3 France Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

5.2 France Prostate Specific Antigen (PSA) Testing Sales and Market Share by Manufacturers

5.3 France Prostate Specific Antigen (PSA) Testing Sales and Market Share by Type

5.4 France Prostate Specific Antigen (PSA) Testing Sales and Market Share by Applications

6 Italy Prostate Specific Antigen (PSA) Testing (Volume, Value and Sales Price)

6.1 Italy Prostate Specific Antigen (PSA) Testing Sales and Value (2011-2021)

6.1.1 Italy Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

6.1.2 Italy Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

6.1.3 Italy Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

6.2 Italy Prostate Specific Antigen (PSA) Testing Sales and Market Share by Manufacturers

6.3 Italy Prostate Specific Antigen (PSA) Testing Sales and Market Share by Type

6.4 Italy Prostate Specific Antigen (PSA) Testing Sales and Market Share by Applications

7 Russia Prostate Specific Antigen (PSA) Testing (Volume, Value and Sales Price)

7.1 Russia Prostate Specific Antigen (PSA) Testing Sales and Value (2011-2021)

7.1.1 Russia Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

7.1.2 Russia Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

7.1.3 Russia Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

7.2 Russia Prostate Specific Antigen (PSA) Testing Sales and Market Share by Manufacturers

7.3 Russia Prostate Specific Antigen (PSA) Testing Sales and Market Share by Type

7.4 Russia Prostate Specific Antigen (PSA) Testing Sales and Market Share by Applications

8 Spain Prostate Specific Antigen (PSA) Testing (Volume, Value and Sales Price)

8.1 Spain Prostate Specific Antigen (PSA) Testing Sales and Value (2011-2021)

8.1.1 Spain Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

8.1.2 Spain Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

8.1.3 Spain Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

8.2 Spain Prostate Specific Antigen (PSA) Testing Sales and Market Share by Manufacturers

8.3 Spain Prostate Specific Antigen (PSA) Testing Sales and Market Share by Type

8.4 Spain Prostate Specific Antigen (PSA) Testing Sales and Market Share by Applications

9 Europe Prostate Specific Antigen (PSA) Testing Manufacturers Analysis

9.1 Abbott Laboratories, Inc

9.1.1 Company Basic Information,Manufacturing Base and Competitors

9.1.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Abbott Laboratories, Inc (2015 and 2016)

9.2 Bayer AG

9.2.1 Company Basic Information,Manufacturing Base and Competitors

9.2.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Bayer AG (2015 and 2016)

9.3 Beckman Coulter, Inc

9.3.1 Company Basic Information,Manufacturing Base and Competitors

9.3.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Beckman Coulter, Inc (2015 and 2016)

9.4 GE Helathcare

9.4.1 Company Basic Information,Manufacturing Base and Competitors

9.4.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of GE Helathcare (2015 and 2016)

9.5 GlaxoSmithKline, plc

9.5.1 Company Basic Information,Manufacturing Base and Competitors

9.5.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of GlaxoSmithKline, plc (2015 and 2016)

9.6 Novartis Pharma AG

9.6.1 Company Basic Information,Manufacturing Base and Competitors

9.6.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Novartis Pharma AG (2015 and 2016)

9.7 UroLogix, Inc

9.7.1 Company Basic Information,Manufacturing Base and Competitors

9.7.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of UroLogix, Inc (2015 and 2016)

9.8 Bristol - Myers Squibb Company

9.8.1 Company Basic Information,Manufacturing Base and Competitors

9.8.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Bristol - Myers Squibb Company (2015 and 2016)

9.9 AstraZeneca plc

9.9.1 Company Basic Information,Manufacturing Base and Competitors

9.9.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of AstraZeneca plc (2015 and 2016)

9.10 Johnson & Johnson Diagnostics

9.10.1 Company Basic Information,Manufacturing Base and Competitors

9.10.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Johnson & Johnson Diagnostics (2015 and 2016)

9.11 BioChem Pharma

9.11.1 Company Basic Information,Manufacturing Base and Competitors

9.11.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.11.2.1 Type I

9.11.2.2 Type II

9.11.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of BioChem Pharma (2015 and 2016)

9.12 Pharmacia Delfia

9.12.1 Company Basic Information,Manufacturing Base and Competitors

9.12.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.12.2.1 Type I

9.12.2.2 Type II

9.12.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Pharmacia Delfia (2015 and 2016)

9.13 Roche Diagnostics

9.13.1 Company Basic Information,Manufacturing Base and Competitors

9.13.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.13.2.1 Type I

9.13.2.2 Type II

9.13.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Roche Diagnostics (2015 and 2016)

9.14 Olympus

9.14.1 Company Basic Information,Manufacturing Base and Competitors

9.14.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.14.2.1 Type I

9.14.2.2 Type II

9.14.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Olympus (2015 and 2016)

9.15 Tosho

9.15.1 Company Basic Information,Manufacturing Base and Competitors

9.15.2 Prostate Specific Antigen (PSA) Testing Product Type and Technology

9.15.2.1 Type I

9.15.2.2 Type II

9.15.3 Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Tosho (2015 and 2016)

10 Prostate Specific Antigen (PSA) Testing Technology and Development Trend

10.1 Prostate Specific Antigen (PSA) Testing Technology Analysis

10.2 Prostate Specific Antigen (PSA) Testing Technology Development Trend

11 Research Findings and Conclusion

List Of Tables and Figures

Figure Picture of Prostate Specific Antigen (PSA) Testing

Table Classification of Prostate Specific Antigen (PSA) Testing

Figure Europe Sales Market Share of Prostate Specific Antigen (PSA) Testing by Types in 2015

Figure Free Prostate Specific Antigen Test Picture

Figure Complex Prostate Specific Antigen Test Picture

Figure Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test Picture

Table Applications of Prostate Specific Antigen (PSA) Testing

Figure Europe Sales Market Share of Prostate Specific Antigen (PSA) Testing by Applications in 2015

Figure Germany Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Figure France Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Figure UK Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Figure Italy Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Figure Spain Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Figure Russia Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Table Europe Prostate Specific Antigen (PSA) Testing Sales, Revenue and Price (2011-2021)

Figure Europe Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

Figure Europe Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Table Europe Prostate Specific Antigen (PSA) Testing Sales of Key Manufacturers (2015 and 2016)

Table Europe Prostate Specific Antigen (PSA) Testing Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Prostate Specific Antigen (PSA) Testing Sales Share by Manufacturers

Figure 2016 Prostate Specific Antigen (PSA) Testing Sales Share by Manufacturers

Table Europe Prostate Specific Antigen (PSA) Testing Revenue by Manufacturers (2015 and 2016)

Table Europe Prostate Specific Antigen (PSA) Testing Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Prostate Specific Antigen (PSA) Testing Revenue Share by Manufacturers

Table 2016 Europe Prostate Specific Antigen (PSA) Testing Revenue Share by Manufacturers

Table Europe Prostate Specific Antigen (PSA) Testing Sales and Market Share by Type (2011-2021)

Table Europe Prostate Specific Antigen (PSA) Testing Sales Share by Type (2011-2021)

Figure Sales Market Share of Prostate Specific Antigen (PSA) Testing by Type (2011-2021)

Figure Europe Prostate Specific Antigen (PSA) Testing Sales Growth Rate by Type (2011-2021)

Table Europe Prostate Specific Antigen (PSA) Testing Revenue and Market Share by Type (2011-2021)

Table Europe Prostate Specific Antigen (PSA) Testing Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Prostate Specific Antigen (PSA) Testing by Type (2011-2021)

Figure Europe Prostate Specific Antigen (PSA) Testing Revenue Growth Rate by Type (2011-2021)

Table Europe Prostate Specific Antigen (PSA) Testing Sales and Market Share by Regions (2011-2021)

Table Europe Prostate Specific Antigen (PSA) Testing Sales Share by Regions (2011-2021)

Figure Sales Market Share of Prostate Specific Antigen (PSA) Testing by Regions (2011-2021)

Figure Europe Prostate Specific Antigen (PSA) Testing Sales Growth Rate by Regions (2011-2021)

Table Europe Prostate Specific Antigen (PSA) Testing Revenue and Market Share by Regions (2011-2021)

Table Europe Prostate Specific Antigen (PSA) Testing Revenue Share by Regions (2011-2021)

Figure Revenue Market Share of Prostate Specific Antigen (PSA) Testing by Regions (2011-2021)

Figure Europe Prostate Specific Antigen (PSA) Testing Revenue Growth Rate by Regions (2011-2021)

Table Europe Prostate Specific Antigen (PSA) Testing Sales and Market Share by Application (2011-2021)

Table Europe Prostate Specific Antigen (PSA) Testing Sales Share by Application (2011-2021)

Figure Sales Market Share of Prostate Specific Antigen (PSA) Testing by Application (2011-2021)

Figure Europe Prostate Specific Antigen (PSA) Testing Sales Growth Rate by Application (2011-2021)

Figure Germany Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

Figure Germany Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Figure Germany Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

Table Germany Prostate Specific Antigen (PSA) Testing Sales by Manufacturers (2015 and 2016)

Table Germany Prostate Specific Antigen (PSA) Testing Market Share by Manufacturers (2015 and 2016)

Table Germany Prostate Specific Antigen (PSA) Testing Sales by Type (2015 and 2016)

Table Germany Prostate Specific Antigen (PSA) Testing Market Share by Type (2015 and 2016)

Table Germany Prostate Specific Antigen (PSA) Testing Sales by Applications (2015 and 2016)

Table Germany Prostate Specific Antigen (PSA) Testing Market Share by Applications (2015 and 2016)

Figure UK Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

Figure UK Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Figure UK Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

Table UK Prostate Specific Antigen (PSA) Testing Sales by Manufacturers (2015 and 2016)

Table UK Prostate Specific Antigen (PSA) Testing Market Share by Manufacturers (2015 and 2016)

Table UK Prostate Specific Antigen (PSA) Testing Sales by Type (2015 and 2016)

Table UK Prostate Specific Antigen (PSA) Testing Market Share by Type (2015 and 2016)

Table UK Prostate Specific Antigen (PSA) Testing Sales by Applications (2015 and 2016)

Table UK Prostate Specific Antigen (PSA) Testing Market Share by Applications (2015 and 2016)

Figure France Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

Figure France Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Figure France Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

Table France Prostate Specific Antigen (PSA) Testing Sales by Manufacturers (2015 and 2016)

Table France Prostate Specific Antigen (PSA) Testing Market Share by Manufacturers (2015 and 2016)

Table France Prostate Specific Antigen (PSA) Testing Sales by Type (2015 and 2016)

Table France Prostate Specific Antigen (PSA) Testing Market Share by Type (2015 and 2016)

Table France Prostate Specific Antigen (PSA) Testing Sales by Applications (2015 and 2016)

Table France Prostate Specific Antigen (PSA) Testing Market Share by Applications (2015 and 2016)

Figure Italy Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

Figure Italy Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Figure Italy Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

Table Italy Prostate Specific Antigen (PSA) Testing Sales by Manufacturers (2015 and 2016)

Table Italy Prostate Specific Antigen (PSA) Testing Market Share by Manufacturers (2015 and 2016)

Table Italy Prostate Specific Antigen (PSA) Testing Sales by Type (2015 and 2016)

Table Italy Prostate Specific Antigen (PSA) Testing Market Share by Type (2015 and 2016)

Table Italy Prostate Specific Antigen (PSA) Testing Sales by Applications (2015 and 2016)

Table Italy Prostate Specific Antigen (PSA) Testing Market Share by Applications (2015 and 2016)

Figure Russia Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

Figure Russia Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Figure Russia Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

Table Russia Prostate Specific Antigen (PSA) Testing Sales by Manufacturers (2015 and 2016)

Table Russia Prostate Specific Antigen (PSA) Testing Market Share by Manufacturers (2015 and 2016)

Table Russia Prostate Specific Antigen (PSA) Testing Sales by Type (2015 and 2016)

Table Russia Prostate Specific Antigen (PSA) Testing Market Share by Type (2015 and 2016)

Table Russia Prostate Specific Antigen (PSA) Testing Sales by Applications (2015 and 2016)

Table Russia Prostate Specific Antigen (PSA) Testing Market Share by Applications (2015 and 2016)

Figure Spain Prostate Specific Antigen (PSA) Testing Sales and Growth Rate (2011-2021)

Figure Spain Prostate Specific Antigen (PSA) Testing Revenue and Growth Rate (2011-2021)

Figure Spain Prostate Specific Antigen (PSA) Testing Sales Price Trend (2011-2021)

Table Spain Prostate Specific Antigen (PSA) Testing Sales by Manufacturers (2015 and 2016)

Table Spain Prostate Specific Antigen (PSA) Testing Market Share by Manufacturers (2015 and 2016)

Table Spain Prostate Specific Antigen (PSA) Testing Sales by Type (2015 and 2016)

Table Spain Prostate Specific Antigen (PSA) Testing Market Share by Type (2015 and 2016)

Table Spain Prostate Specific Antigen (PSA) Testing Sales by Applications (2015 and 2016)

Table Spain Prostate Specific Antigen (PSA) Testing Market Share by Applications (2015 and 2016)

Table Abbott Laboratories, Inc Basic Information List

Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Abbott Laboratories, Inc (2015 and 2016)

Table Bayer AG Basic Information List

Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Bayer AG (2015 and 2016)

Table Beckman Coulter, Inc Basic Information List

Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Beckman Coulter, Inc (2015 and 2016)

Table GE Helathcare Basic Information List

Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of GE Helathcare (2015 and 2016)

Table GlaxoSmithKline, plc Basic Information List

Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of GlaxoSmithKline, plc (2015 and 2016)

Table Novartis Pharma AG Basic Information List

Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Novartis Pharma AG (2015 and 2016)

Table UroLogix, Inc Basic Information List

Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of UroLogix, Inc (2015 and 2016)

Table Bristol - Myers Squibb Company Basic Information List

Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Bristol - Myers Squibb Company (2015 and 2016)

Table AstraZeneca plc Basic Information List

Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of AstraZeneca plc (2015 and 2016)

Table Johnson & Johnson Diagnostics Basic Information List

Table Prostate Specific Antigen (PSA) Testing Sales, Revenue, Price of Johnson & Johnson Diagnostics (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
View Details
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370
View Details
Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023

Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...

  • Publish Date: May 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research